Structure-based analysis of A19D, a variant of transthyretin involved in familial amyloid cardiomyopathy

Priscila Ferreira, Oliveira Sant'Anna, Nathalia Varejão, Cinthia Lima, Shenia Novis, Renata V. Barbosa, Concy M. Caldeira, Franklin D. Rumjanek, Salvador Ventura, Marcia W. Cruz, Debora Foguel

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)


Transthyretin (TTR) is a tetrameric beta-sheet-rich protein. Its deposits have been implicated in four different amyloid diseases. Although aggregation of the wild-type sequence is responsible for the senile form of the disease, more than one hundred variants have been described thus far, most of which confer a more amyloidogenic character to TTR, mainly because they compromise the stability of the protein in relation to monomer formation, which upon misfolding is intrinsically aggregation-prone. We report the case of a Brazilian patient suffering from a severe cardiomyopathy who carries a rare mutation in exon 2 of the TTR gene that results in an Ala to Asp substitution at position 19 (A19D). The putative pathogenic mechanisms of this variant were analyzed in silico. We constructed a structural model for the A19D tetramer from which its thermodynamic stability was compared to that displayed by the V30M (more amyloidogenic than WT-TTR) and T119M (non-amyloidogenic) variants. The FoldX force field predicted that A19D and V30M are 10.88 and 8.07 kCal/mol less stable than the WT-TTR, while T119M is 5.15 kCal/mol more stable, which is consistent with the aggregation propensities exhibited by these variants. We analyzed the step in which the tetramer-dimer-monomer-unfolded monomer equilibrium might contribute the most to the increased or decreased amyloidogenicity in each variant. Our results suggest that the concentration of four non-native negative charges occur inside thyroxine-binding channels, and the loss of contacts at both the tetrameric and dimeric interfaces would account for an overall decreased stability of the tetramer and the consequent enhanced amyloidogenicity of the A19D variant. As far as we know, this is the first description of a non-V30M mutation in Brazil. © 2013 Ferreira et al.
Original languageEnglish
Article numbere82484
JournalPLoS ONE
Issue number12
Publication statusPublished - 17 Dec 2013


Dive into the research topics of 'Structure-based analysis of A19D, a variant of transthyretin involved in familial amyloid cardiomyopathy'. Together they form a unique fingerprint.

Cite this